Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 1.000 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.549 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.528 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.516 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.513 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.510 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.509 | |
3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.500 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.499 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.493 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.492 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.491 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.489 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.488 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.488 | |
3pwh | ZMA | Adenosine receptor A2a | / | 0.488 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.484 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.484 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.483 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.482 | |
4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.482 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.478 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.478 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.476 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.475 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.475 | |
4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.474 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.472 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.471 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.471 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.469 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.468 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.468 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.468 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.468 | |
1j3k | WRA | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.467 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.467 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.466 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.466 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.465 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.465 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.465 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.465 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.464 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.464 | |
4h97 | 53S | Dihydrofolate reductase | 1.5.1.3 | 0.464 | |
4oth | DRN | Serine/threonine-protein kinase N1 | / | 0.464 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.463 | |
3jsu | KA5 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.463 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.463 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.462 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.461 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
3wv9 | FEG | Hmd co-occurring protein HcgE | / | 0.461 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.461 | |
1e6e | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.460 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.460 | |
4ixf | IXF | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.459 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.458 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.458 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
3g5s | FAD | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO | / | 0.458 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.458 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.458 | |
3rey | XAC | Adenosine receptor A2a | / | 0.458 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.457 | |
4jlk | 1NO | Deoxycytidine kinase | 2.7.1.74 | 0.457 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.456 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.456 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.456 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.455 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.455 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.455 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.455 | |
2z78 | H86 | Geranylgeranyl pyrophosphate synthase | / | 0.454 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.454 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.454 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.453 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.453 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.453 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
3x0a | 5GP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.453 | |
1fgi | SU1 | Fibroblast growth factor receptor 1 | / | 0.452 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
3oqk | S52 | Renin | 3.4.23.15 | 0.452 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.452 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.452 | |
4j6c | STR | Cytochrome P450 monooxygenase | / | 0.452 | |
4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.451 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.451 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.450 | |
2w3v | TOP | Dihydrofolate reductase | / | 0.450 | |
3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.450 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.450 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.450 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.448 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.448 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.448 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
4twp | AXI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
4xhg | ADP | Uncharacterized protein | / | 0.448 | |
1drb | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.447 | |
3qly | 55V | Uncharacterized protein | / | 0.447 | |
3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
4em9 | TCE | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.447 | |
1cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.446 | |
2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.446 | |
3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.446 | |
3tq9 | MTX | Dihydrofolate reductase | / | 0.446 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
3zsg | T75 | Mitogen-activated protein kinase 14 | / | 0.446 | |
4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.446 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.446 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
1siq | FAD | Glutaryl-CoA dehydrogenase, mitochondrial | 1.3.8.6 | 0.445 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.445 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.445 | |
3k1w | BFX | Renin | 3.4.23.15 | 0.445 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.445 | |
4a4l | 939 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.445 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.445 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.445 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.445 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.445 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.444 | |
1w7k | ADP | Dihydrofolate synthase/folylpolyglutamate synthase | 6.3.2.12 | 0.444 | |
2fzh | DH1 | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.444 | |
3q5i | ANP | Protein kinase, putative | / | 0.444 | |
4ele | 31I | Dihydrofolate reductase | / | 0.444 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.444 | |
4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.443 | |
4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.443 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.443 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.442 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.442 | |
3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.442 | |
3ogq | AB1 | Pol polyprotein | / | 0.442 | |
3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.442 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.442 | |
4z64 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.442 | |
1ddr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
2ph5 | NAD | Homospermidine synthase | / | 0.441 | |
2vf0 | F89 | Thymidylate synthase | / | 0.441 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.441 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.441 | |
4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.441 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.440 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.440 |